Sign inJoin waitlistJoin the waitlist

Hyunseok Kang

Clinical Instructor of Medicine · Stanford Health Care

Credentials: · · · · · · ·

History

Hematology and Medical Oncology
Emory University
2010–2013
SAINT LUKES ROOSEVELT HOSPITAL
2007–2010
Hopkins University School of Medicine
Doctor of Medicine
1998–2002
Yonsei University

Research

Evolution of Neoantigen Landscape during Immune Checkpoint Blockade in Non-Small Cell Lung Cancer
Cancer Discovery · 2017 · 764 citations
Antitumor Activity of Pembrolizumab in Biomarker-Unselected Patients With Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma: Results From the Phase Ib KEYNOTE-012…
Journal of Clinical Oncology · 2016 · 701 citations
Efficacy of Selpercatinib in RET-Altered Thyroid Cancers
New England Journal of Medicine · 2020 · 631 citations

Patrick Ha
17 papers
Ana Kiess
14 papers · 1 as a resident
Carole Fakhry
11 papers
Harry Quon
11 papers
Alain Algazi
10 papers
Katherine Wai
10 papers · 3 as a resident
Ranee Mehra
10 papers
Chase Heaton
9 papers
Christine Gourin
8 papers
David Eisele
8 papers
FW
Francis Worden
8 papers
Jared Weiss
8 papers

Clinical trials

NT-I7 for the Treatment of Recurrent Squamous Cell Carcinoma of Head and Neck Undergoing Surgery
Principal investigator · Terminated · Phase 1
Hyunseok Kang, MD
2021–2025
Sodium Thiosulfate in Preventing Ototoxicity for Squamous Cell Cancer Patients Undergoing Chemoradiation With Cisplatin
Principal investigator · Completed · Phase 2
Hyunseok Kang, MD
2020–2023
A Study to Evaluate CRB-701 Compared to Investigator's Choice Therapy in Previously Treated Oropharyngeal Squamous Cell Carcinoma
Site PI · Not yet recruiting · Phase 3
Corbus Pharmaceuticals Inc.
2026–2029